Cargando…

Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis

We aimed to examine the effect of Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) level on survival comparing with other laboratory liver fibrosis markers in hepatitis C virus (HCV)-related compensated liver cirrhosis (LC) (n = 165). For assessing prognostic performance o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Kunihiro, Takata, Ryo, Nishikawa, Hiroki, Enomoto, Hirayuki, Ishii, Akio, Iwata, Yoshinori, Miyamoto, Yuho, Ishii, Noriko, Yuri, Yukihisa, Nakano, Chikage, Nishimura, Takashi, Yoh, Kazunori, Aizawa, Nobuhiro, Sakai, Yoshiyuki, Ikeda, Naoto, Takashima, Tomoyuki, Iijima, Hiroko, Nishiguchi, Shuhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037777/
https://www.ncbi.nlm.nih.gov/pubmed/27626413
http://dx.doi.org/10.3390/ijms17091500
_version_ 1782455811704881152
author Hasegawa, Kunihiro
Takata, Ryo
Nishikawa, Hiroki
Enomoto, Hirayuki
Ishii, Akio
Iwata, Yoshinori
Miyamoto, Yuho
Ishii, Noriko
Yuri, Yukihisa
Nakano, Chikage
Nishimura, Takashi
Yoh, Kazunori
Aizawa, Nobuhiro
Sakai, Yoshiyuki
Ikeda, Naoto
Takashima, Tomoyuki
Iijima, Hiroko
Nishiguchi, Shuhei
author_facet Hasegawa, Kunihiro
Takata, Ryo
Nishikawa, Hiroki
Enomoto, Hirayuki
Ishii, Akio
Iwata, Yoshinori
Miyamoto, Yuho
Ishii, Noriko
Yuri, Yukihisa
Nakano, Chikage
Nishimura, Takashi
Yoh, Kazunori
Aizawa, Nobuhiro
Sakai, Yoshiyuki
Ikeda, Naoto
Takashima, Tomoyuki
Iijima, Hiroko
Nishiguchi, Shuhei
author_sort Hasegawa, Kunihiro
collection PubMed
description We aimed to examine the effect of Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) level on survival comparing with other laboratory liver fibrosis markers in hepatitis C virus (HCV)-related compensated liver cirrhosis (LC) (n = 165). For assessing prognostic performance of continuous fibrosis markers, we adapted time-dependent receiver operating characteristics (ROC) curves for clinical outcome. In time-dependent ROC analysis, annual area under the ROCs (AUROCs) were plotted. We also calculated the total sum of AUROCs in all time-points (TAAT score) in each fibrosis marker. WFA(+)-M2BP value ranged from 0.66 cutoff index (COI) to 19.95 COI (median value, 5.29 COI). Using ROC analysis for survival, the optimal cutoff point for WFA(+)-M2BP was 6.15 COI (AUROC = 0.79348, sensitivity = 80.0%, specificity = 74.78%). The cumulative five-year survival rate in patients with WFA(+)-M2BP ≥ 6.15 COI (n = 69) was 43.99%, while that in patients with WFA(+)-M2BP < 6.15 COI (n = 96) was 88.40% (p < 0.0001). In the multivariate analysis, absence of hepatocellular carcinoma (p = 0.0008), WFA(+)-M2BP < 6.15 COI (p = 0.0132), achievement of sustained virological response (p < 0.0001) and des-γ-carboxy prothrombin < 41 mAU/mL (p = 0.0018) were significant favorable predictors linked to survival. In time-dependent ROC analysis in all cases, WFA(+)-M2BP had the highest TAAT score among liver fibrosis markers. In conclusion, WFA(+)-M2BP can be a useful predictor in HCV-related compensated LC.
format Online
Article
Text
id pubmed-5037777
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-50377772016-09-29 Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis Hasegawa, Kunihiro Takata, Ryo Nishikawa, Hiroki Enomoto, Hirayuki Ishii, Akio Iwata, Yoshinori Miyamoto, Yuho Ishii, Noriko Yuri, Yukihisa Nakano, Chikage Nishimura, Takashi Yoh, Kazunori Aizawa, Nobuhiro Sakai, Yoshiyuki Ikeda, Naoto Takashima, Tomoyuki Iijima, Hiroko Nishiguchi, Shuhei Int J Mol Sci Article We aimed to examine the effect of Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) level on survival comparing with other laboratory liver fibrosis markers in hepatitis C virus (HCV)-related compensated liver cirrhosis (LC) (n = 165). For assessing prognostic performance of continuous fibrosis markers, we adapted time-dependent receiver operating characteristics (ROC) curves for clinical outcome. In time-dependent ROC analysis, annual area under the ROCs (AUROCs) were plotted. We also calculated the total sum of AUROCs in all time-points (TAAT score) in each fibrosis marker. WFA(+)-M2BP value ranged from 0.66 cutoff index (COI) to 19.95 COI (median value, 5.29 COI). Using ROC analysis for survival, the optimal cutoff point for WFA(+)-M2BP was 6.15 COI (AUROC = 0.79348, sensitivity = 80.0%, specificity = 74.78%). The cumulative five-year survival rate in patients with WFA(+)-M2BP ≥ 6.15 COI (n = 69) was 43.99%, while that in patients with WFA(+)-M2BP < 6.15 COI (n = 96) was 88.40% (p < 0.0001). In the multivariate analysis, absence of hepatocellular carcinoma (p = 0.0008), WFA(+)-M2BP < 6.15 COI (p = 0.0132), achievement of sustained virological response (p < 0.0001) and des-γ-carboxy prothrombin < 41 mAU/mL (p = 0.0018) were significant favorable predictors linked to survival. In time-dependent ROC analysis in all cases, WFA(+)-M2BP had the highest TAAT score among liver fibrosis markers. In conclusion, WFA(+)-M2BP can be a useful predictor in HCV-related compensated LC. MDPI 2016-09-12 /pmc/articles/PMC5037777/ /pubmed/27626413 http://dx.doi.org/10.3390/ijms17091500 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hasegawa, Kunihiro
Takata, Ryo
Nishikawa, Hiroki
Enomoto, Hirayuki
Ishii, Akio
Iwata, Yoshinori
Miyamoto, Yuho
Ishii, Noriko
Yuri, Yukihisa
Nakano, Chikage
Nishimura, Takashi
Yoh, Kazunori
Aizawa, Nobuhiro
Sakai, Yoshiyuki
Ikeda, Naoto
Takashima, Tomoyuki
Iijima, Hiroko
Nishiguchi, Shuhei
Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
title Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
title_full Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
title_fullStr Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
title_full_unstemmed Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
title_short Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis
title_sort impact of wisteria floribunda agglutinin-positive mac-2-binding protein in patients with hepatitis c virus-related compensated liver cirrhosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037777/
https://www.ncbi.nlm.nih.gov/pubmed/27626413
http://dx.doi.org/10.3390/ijms17091500
work_keys_str_mv AT hasegawakunihiro impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT takataryo impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT nishikawahiroki impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT enomotohirayuki impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT ishiiakio impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT iwatayoshinori impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT miyamotoyuho impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT ishiinoriko impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT yuriyukihisa impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT nakanochikage impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT nishimuratakashi impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT yohkazunori impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT aizawanobuhiro impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT sakaiyoshiyuki impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT ikedanaoto impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT takashimatomoyuki impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT iijimahiroko impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis
AT nishiguchishuhei impactofwisteriafloribundaagglutininpositivemac2bindingproteininpatientswithhepatitiscvirusrelatedcompensatedlivercirrhosis